13 Oct JAMA Study: 340B Does Not Raise Drug Prices
By 340B Matters The drug industry and its surrogates have contended for years that the 340B Drug Discount Program somehow raises drug prices overall. It has argued that discounts provided under 340B to safety-net hospitals and clinics are offset by manufacturers when selling those same medicines at...